Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638189 · ClinicalTrials.gov registry record · Phase 2
CBD Knee Osteoarthritis Study
A Phase 2 study, sponsored by University of Tennessee.
- Not yet
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT07638189 is a Phase 2 study that has not yet begun recruiting, run by University of Tennessee. The registered enrollment target is 30 participants.
The verdict
NCT07638189, a Phase 2 study, has not yet begun recruiting, sponsored by University of Tennessee.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
Osteoarthritis of the knee is a common cause of pain in the US. The currently available medicines for knee osteoarthritis sometimes are not effective at relieving the pain or have unacceptable side effects. Thus, alternate pain relieving treatments are needed. CBD, an active chemical from the hemp derived cannabis sativa plant, has received a lot of attention for its potential pain relieving properties, but there has been limited research to find out if topically applied CBD can decrease pain from knee osteoarthritis. CBD lacks the psychoactive effects seen with marijuana use, because it does not contain THC which is responsible for those effects in marijuana. It is legal to use CBD in the State of Tennessee (site of study). The CBD Knee Study is sponsored by the University of Tennessee Health Science Center and is a collaborative effort between doctors at UT and Campbell Clinic. In the CBD Knee Study, the investigators are examining whether topically applied CBD dissolved in Castor Oil will relieve knee pain in persons with knee osteoarthritis. Persons who take part in the study would need to come for study visits, fill out questionnaires about their health and knee pain, and would be asked to use the topical study oil on their knees. Taking part in the CBD Knee Study is voluntary.
Interventions
- DIETARY_SUPPLEMENT Cannabidiol (CBD)
- OTHER Castor Oil (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07638189
The ClinicalTrials.gov registry entry for NCT07638189 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cannabidiol (CBD) is the first listed.
NCT07638189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07638189 about?
NCT07638189 is a clinical study titled "CBD Knee Osteoarthritis Study". Osteoarthritis of the knee is a common cause of pain in the US. The currently available medicines for knee osteoarthritis sometimes are not effective at relieving the pain or have unacceptable side effects. Thus, alternate pain relieving treatments are needed. CBD, an active chemical from the hemp ...
What is the current status of trial NCT07638189?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-07-01. Estimated completion is 2028-03-30.
What interventions are being tested in trial NCT07638189?
The interventions under investigation include: Cannabidiol (CBD) (DIETARY_SUPPLEMENT), Castor Oil (Placebo) (OTHER).
Who is sponsoring clinical trial NCT07638189?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.